2025-01-17 03:54:01
CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS1003 in patients with advanced solid tumors at ESMO 2021
Corporate/ 2023-07-23
CStone presents preliminary results from...

SUZHOU,China,Sept. 19,2021-- CStone Pharmaceuticals ("CStone",HKEX: 2616),a leading biopharmaceutical company focused on the resea...

Qynapse Unveils Strategic Rebrand To Support Accelerated Growth And New Corporate Vision
Health/ 2023-07-22
Qynapse Unveils Strategic Rebrand To Sup...

BOSTON,Sept. 20,2021-- Qynapse Inc.,a medical technology company commercializing an AI-powered neuroimaging software platform for central ne...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release